Acronym
CORE CTC2
Code
BOF/COR/2024/003
Duration
01 February 2024 → 31 January 2027
Funding
Regional and community funding: Special Research Fund
Promotor-spokesperson
Research disciplines
-
Medical and health sciences
- Gynaecology
- Autoimmunity
- Cancer biology
- Cancer diagnosis
- Cancer prevention
- Cancer therapy
- Adaptive immunology
- Allergology
- Applied immunology
- Autoimmunity
- Immunogenetics
- Inflammation
- Innate immunity
- Transplantation immunology
- Vaccinology
- Cell death
- Cell division
- Cell growth and development
- Cell movement
- Cell signalling
- Cellular interactions and extracellular matrix
- Cytoskeleton
- Developmental biology
- Intracellular compartments and transport
- Membrane structure and transport
- Posttranslational modifications
- Stem cell biology
- Structural biology
Keywords
established cell lines
(advanced) culture conditions
primary cells
human disease
authentication
(pluripotent) stem cells
sterility (mycoplasma)
Project description
CORE CTC² has a main goal to provide and centralize all relevant basic equipment and expertise within the domain of tissue and cell culture of human origin (or animal models representing human disease).